Gene Delivery Technologies - Global Market Outlook (2020-2028)
According to Stratistics MRC, the Global Gene Delivery Technologies Market is accounted for $2.60 billion in 2020 and is expected to reach $9.19 billion by 2028 growing at a CAGR of 17.1% during the forecast period. Advantages like briefness and nontoxicity nature, technological advancements in viral vectors, growing pipeline of advanced therapies, are the factors driving the market growth. However, several clinical challenges associated with viral systems have spurred the usage of chemical methods which may restrain the growth of the market.
Gene delivery is the process of introducing foreign gene delivery, such as DNA or RNA, into host cells, the technologies used to implement the gene delivery are gene delivery technologies. Gene delivery technology is widely applied for various diseases treatment caused from bacterial infections, exterior chemical toxins, viral invasions, malignant tumours and endogenous genetic defects. The advent of cell and gene therapies played a major role in reshaping the entire pharmaceutical ecosystem by transforming the treatment of genetic and intractable diseases.
Based on the application, the gene therapy segment is going to have lucrative growth during the forecast period due to the growing acceptance of gene-based therapies and the consequent increase in the number of clinical research initiatives have fuelled the revenue generation in this segment. Increasing acceptance of gene therapy products worldwide has also accelerated the segment growth.
By geography, North America is going to have high growth during the forecast period due to the substantial number of clinical trials are underway to assess the efficacy and safety of gene therapies as a viable treatment for incurable diseases such as cancer, genetic disorders, HIV in the U.S., Many innovative projects covering viral vector-based gene therapy trials for rare conditions are being introduced in North America. These factors increase the demand of the North America region in the market for gene delivery technologies.
Some of the key players profiled in the Gene Delivery Technologies Market include Bio-Rad Laboratories, Inc., Catalent Inc., OriGene Technologies, Inc., Oxford Biomedica, Promega Corporation, QIAGEN, SignaGen Laboratories, Sirion-Biotech GmbH, System Biosciences llc, Takara Bio Inc., Thermo Fisher Scientific, Inc., Vectalys and Horizon Discovery Group Plc.
Methods Covered:
All the customers of this report will be entitled to receive one of the following free customization options:
Gene delivery is the process of introducing foreign gene delivery, such as DNA or RNA, into host cells, the technologies used to implement the gene delivery are gene delivery technologies. Gene delivery technology is widely applied for various diseases treatment caused from bacterial infections, exterior chemical toxins, viral invasions, malignant tumours and endogenous genetic defects. The advent of cell and gene therapies played a major role in reshaping the entire pharmaceutical ecosystem by transforming the treatment of genetic and intractable diseases.
Based on the application, the gene therapy segment is going to have lucrative growth during the forecast period due to the growing acceptance of gene-based therapies and the consequent increase in the number of clinical research initiatives have fuelled the revenue generation in this segment. Increasing acceptance of gene therapy products worldwide has also accelerated the segment growth.
By geography, North America is going to have high growth during the forecast period due to the substantial number of clinical trials are underway to assess the efficacy and safety of gene therapies as a viable treatment for incurable diseases such as cancer, genetic disorders, HIV in the U.S., Many innovative projects covering viral vector-based gene therapy trials for rare conditions are being introduced in North America. These factors increase the demand of the North America region in the market for gene delivery technologies.
Some of the key players profiled in the Gene Delivery Technologies Market include Bio-Rad Laboratories, Inc., Catalent Inc., OriGene Technologies, Inc., Oxford Biomedica, Promega Corporation, QIAGEN, SignaGen Laboratories, Sirion-Biotech GmbH, System Biosciences llc, Takara Bio Inc., Thermo Fisher Scientific, Inc., Vectalys and Horizon Discovery Group Plc.
Methods Covered:
- Ex-Vivo
- In-Vivo
- In Vitro
- Gene Therapy
- Cell Therapy
- Vaccines
- Research
- Biological
- Chemical
- Physical
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- Italy
- France
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- South Korea
- Rest of Asia Pacific
- South America
- Argentina
- Brazil
- Chile
- Rest of South America
- Middle East & Africa
- Saudi Arabia
- UAE
- Qatar
- South Africa
- Rest of Middle East & Africa
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2019, 2020, 2021, 2025, and 2028
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
All the customers of this report will be entitled to receive one of the following free customization options:
- Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
- Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
- Competitive Benchmarking
- Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
1 EXECUTIVE SUMMARY
2 PREFACE
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 MARKET TREND ANALYSIS
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 Emerging Markets
3.8 Impact of Covid-19
4 PORTERS FIVE FORCE ANALYSIS
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 GLOBAL GENE DELIVERY TECHNOLOGIES MARKET, BY METHOD
5.1 Introduction
5.2 Ex-Vivo
5.3 In-Vivo
5.4 In Vitro
6 GLOBAL GENE DELIVERY TECHNOLOGIES MARKET, BY APPLICATION
6.1 Introduction
6.2 Gene Therapy
6.3 Cell Therapy
6.4 Vaccines
6.5 Research
7 GLOBAL GENE DELIVERY TECHNOLOGIES MARKET, BY MODE
7.1 Introduction
7.2 Biological
7.2.1 Adenoassociated Virus (AAV)
7.2.2 Lentivirus
7.2.3 Retrovirus
7.2.4 Adenovirus
7.2.5 Non-Viral
7.3 Chemical
7.4 Physical
8 GLOBAL GENE DELIVERY TECHNOLOGIES MARKET, BY GEOGRAPHY
8.1 Introduction
8.2 North America
8.2.1 US
8.2.2 Canada
8.2.3 Mexico
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 Italy
8.3.4 France
8.3.5 Spain
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 New Zealand
8.4.6 South Korea
8.4.7 Rest of Asia Pacific
8.5 South America
8.5.1 Argentina
8.5.2 Brazil
8.5.3 Chile
8.5.4 Rest of South America
8.6 Middle East & Africa
8.6.1 Saudi Arabia
8.6.2 UAE
8.6.3 Qatar
8.6.4 South Africa
8.6.5 Rest of Middle East & Africa
9 KEY DEVELOPMENTS
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies
10 COMPANY PROFILING
10.1 Bio-Rad Laboratories, Inc.
10.2 Catalent Inc.
10.3 OriGene Technologies, Inc.
10.4 Oxford Biomedica
10.5 Promega Corporation
10.6 QIAGEN
10.7 SignaGen Laboratories
10.8 Sirion-Biotech GmbH
10.9 System Biosciences llc
10.10 Takara Bio Inc.
10.11 Thermo Fisher Scientific, Inc.
10.12 Vectalys
10.13 Horizon Discovery Group Plc.
2 PREFACE
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 MARKET TREND ANALYSIS
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 Emerging Markets
3.8 Impact of Covid-19
4 PORTERS FIVE FORCE ANALYSIS
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 GLOBAL GENE DELIVERY TECHNOLOGIES MARKET, BY METHOD
5.1 Introduction
5.2 Ex-Vivo
5.3 In-Vivo
5.4 In Vitro
6 GLOBAL GENE DELIVERY TECHNOLOGIES MARKET, BY APPLICATION
6.1 Introduction
6.2 Gene Therapy
6.3 Cell Therapy
6.4 Vaccines
6.5 Research
7 GLOBAL GENE DELIVERY TECHNOLOGIES MARKET, BY MODE
7.1 Introduction
7.2 Biological
7.2.1 Adenoassociated Virus (AAV)
7.2.2 Lentivirus
7.2.3 Retrovirus
7.2.4 Adenovirus
7.2.5 Non-Viral
7.3 Chemical
7.4 Physical
8 GLOBAL GENE DELIVERY TECHNOLOGIES MARKET, BY GEOGRAPHY
8.1 Introduction
8.2 North America
8.2.1 US
8.2.2 Canada
8.2.3 Mexico
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 Italy
8.3.4 France
8.3.5 Spain
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 New Zealand
8.4.6 South Korea
8.4.7 Rest of Asia Pacific
8.5 South America
8.5.1 Argentina
8.5.2 Brazil
8.5.3 Chile
8.5.4 Rest of South America
8.6 Middle East & Africa
8.6.1 Saudi Arabia
8.6.2 UAE
8.6.3 Qatar
8.6.4 South Africa
8.6.5 Rest of Middle East & Africa
9 KEY DEVELOPMENTS
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies
10 COMPANY PROFILING
10.1 Bio-Rad Laboratories, Inc.
10.2 Catalent Inc.
10.3 OriGene Technologies, Inc.
10.4 Oxford Biomedica
10.5 Promega Corporation
10.6 QIAGEN
10.7 SignaGen Laboratories
10.8 Sirion-Biotech GmbH
10.9 System Biosciences llc
10.10 Takara Bio Inc.
10.11 Thermo Fisher Scientific, Inc.
10.12 Vectalys
10.13 Horizon Discovery Group Plc.
LIST OF TABLES
Table 1 Global Gene Delivery Technologies Market Outlook, By Region (2019-2028) (US $MN)
Table 2 Global Gene Delivery Technologies Market Outlook, By Method (2019-2028) (US $MN)
Table 3 Global Gene Delivery Technologies Market Outlook, By Ex-Vivo (2019-2028) (US $MN)
Table 4 Global Gene Delivery Technologies Market Outlook, By In-Vivo (2019-2028) (US $MN)
Table 5 Global Gene Delivery Technologies Market Outlook, By In Vitro (2019-2028) (US $MN)
Table 6 Global Gene Delivery Technologies Market Outlook, By Application (2019-2028) (US $MN)
Table 7 Global Gene Delivery Technologies Market Outlook, By Gene Therapy (2019-2028) (US $MN)
Table 8 Global Gene Delivery Technologies Market Outlook, By Cell Therapy (2019-2028) (US $MN)
Table 9 Global Gene Delivery Technologies Market Outlook, By Vaccines (2019-2028) (US $MN)
Table 10 Global Gene Delivery Technologies Market Outlook, By Research (2019-2028) (US $MN)
Table 11 Global Gene Delivery Technologies Market Outlook, By Mode (2019-2028) (US $MN)
Table 12 Global Gene Delivery Technologies Market Outlook, By Biological (2019-2028) (US $MN)
Table 13 Global Gene Delivery Technologies Market Outlook, By Adenoassociated Virus (AAV) (2019-2028) (US $MN)
Table 14 Global Gene Delivery Technologies Market Outlook, By Lentivirus (2019-2028) (US $MN)
Table 15 Global Gene Delivery Technologies Market Outlook, By Retrovirus (2019-2028) (US $MN)
Table 16 Global Gene Delivery Technologies Market Outlook, By Adenovirus (2019-2028) (US $MN)
Table 17 Global Gene Delivery Technologies Market Outlook, By Non-Viral (2019-2028) (US $MN)
Table 18 Global Gene Delivery Technologies Market Outlook, By Chemical (2019-2028) (US $MN)
Table 19 Global Gene Delivery Technologies Market Outlook, By Physical (2019-2028) (US $MN)
Table 20 North America Gene Delivery Technologies Market Outlook, By Country (2019-2028) (US $MN)
Table 21 North America Gene Delivery Technologies Market Outlook, By Method (2019-2028) (US $MN)
Table 22 North America Gene Delivery Technologies Market Outlook, By Ex-Vivo (2019-2028) (US $MN)
Table 23 North America Gene Delivery Technologies Market Outlook, By In-Vivo (2019-2028) (US $MN)
Table 24 North America Gene Delivery Technologies Market Outlook, By In Vitro (2019-2028) (US $MN)
Table 25 North America Gene Delivery Technologies Market Outlook, By Application (2019-2028) (US $MN)
Table 26 North America Gene Delivery Technologies Market Outlook, By Gene Therapy (2019-2028) (US $MN)
Table 27 North America Gene Delivery Technologies Market Outlook, By Cell Therapy (2019-2028) (US $MN)
Table 28 North America Gene Delivery Technologies Market Outlook, By Vaccines (2019-2028) (US $MN)
Table 29 North America Gene Delivery Technologies Market Outlook, By Research (2019-2028) (US $MN)
Table 30 North America Gene Delivery Technologies Market Outlook, By Mode (2019-2028) (US $MN)
Table 31 North America Gene Delivery Technologies Market Outlook, By Biological (2019-2028) (US $MN)
Table 32 North America Gene Delivery Technologies Market Outlook, By Adenoassociated Virus (AAV) (2019-2028) (US $MN)
Table 33 North America Gene Delivery Technologies Market Outlook, By Lentivirus (2019-2028) (US $MN)
Table 34 North America Gene Delivery Technologies Market Outlook, By Retrovirus (2019-2028) (US $MN)
Table 35 North America Gene Delivery Technologies Market Outlook, By Adenovirus (2019-2028) (US $MN)
Table 36 North America Gene Delivery Technologies Market Outlook, By Non-Viral (2019-2028) (US $MN)
Table 37 North America Gene Delivery Technologies Market Outlook, By Chemical (2019-2028) (US $MN)
Table 38 North America Gene Delivery Technologies Market Outlook, By Physical (2019-2028) (US $MN)
Table 39 Europe Gene Delivery Technologies Market Outlook, By Country (2019-2028) (US $MN)
Table 40 Europe Gene Delivery Technologies Market Outlook, By Method (2019-2028) (US $MN)
Table 41 Europe Gene Delivery Technologies Market Outlook, By Ex-Vivo (2019-2028) (US $MN)
Table 42 Europe Gene Delivery Technologies Market Outlook, By In-Vivo (2019-2028) (US $MN)
Table 43 Europe Gene Delivery Technologies Market Outlook, By In Vitro (2019-2028) (US $MN)
Table 44 Europe Gene Delivery Technologies Market Outlook, By Application (2019-2028) (US $MN)
Table 45 Europe Gene Delivery Technologies Market Outlook, By Gene Therapy (2019-2028) (US $MN)
Table 46 Europe Gene Delivery Technologies Market Outlook, By Cell Therapy (2019-2028) (US $MN)
Table 47 Europe Gene Delivery Technologies Market Outlook, By Vaccines (2019-2028) (US $MN)
Table 48 Europe Gene Delivery Technologies Market Outlook, By Research (2019-2028) (US $MN)
Table 49 Europe Gene Delivery Technologies Market Outlook, By Mode (2019-2028) (US $MN)
Table 50 Europe Gene Delivery Technologies Market Outlook, By Biological (2019-2028) (US $MN)
Table 51 Europe Gene Delivery Technologies Market Outlook, By Adenoassociated Virus (AAV) (2019-2028) (US $MN)
Table 52 Europe Gene Delivery Technologies Market Outlook, By Lentivirus (2019-2028) (US $MN)
Table 53 Europe Gene Delivery Technologies Market Outlook, By Retrovirus (2019-2028) (US $MN)
Table 54 Europe Gene Delivery Technologies Market Outlook, By Adenovirus (2019-2028) (US $MN)
Table 55 Europe Gene Delivery Technologies Market Outlook, By Non-Viral (2019-2028) (US $MN)
Table 56 Europe Gene Delivery Technologies Market Outlook, By Chemical (2019-2028) (US $MN)
Table 57 Europe Gene Delivery Technologies Market Outlook, By Physical (2019-2028) (US $MN)
Table 58 Asia Pacific Gene Delivery Technologies Market Outlook, By Country (2019-2028) (US $MN)
Table 59 Asia Pacific Gene Delivery Technologies Market Outlook, By Method (2019-2028) (US $MN)
Table 60 Asia Pacific Gene Delivery Technologies Market Outlook, By Ex-Vivo (2019-2028) (US $MN)
Table 61 Asia Pacific Gene Delivery Technologies Market Outlook, By In-Vivo (2019-2028) (US $MN)
Table 62 Asia Pacific Gene Delivery Technologies Market Outlook, By In Vitro (2019-2028) (US $MN)
Table 63 Asia Pacific Gene Delivery Technologies Market Outlook, By Application (2019-2028) (US $MN)
Table 64 Asia Pacific Gene Delivery Technologies Market Outlook, By Gene Therapy (2019-2028) (US $MN)
Table 65 Asia Pacific Gene Delivery Technologies Market Outlook, By Cell Therapy (2019-2028) (US $MN)
Table 66 Asia Pacific Gene Delivery Technologies Market Outlook, By Vaccines (2019-2028) (US $MN)
Table 67 Asia Pacific Gene Delivery Technologies Market Outlook, By Research (2019-2028) (US $MN)
Table 68 Asia Pacific Gene Delivery Technologies Market Outlook, By Mode (2019-2028) (US $MN)
Table 69 Asia Pacific Gene Delivery Technologies Market Outlook, By Biological (2019-2028) (US $MN)
Table 70 Asia Pacific Gene Delivery Technologies Market Outlook, By Adenoassociated Virus (AAV) (2019-2028) (US $MN)
Table 71 Asia Pacific Gene Delivery Technologies Market Outlook, By Lentivirus (2019-2028) (US $MN)
Table 72 Asia Pacific Gene Delivery Technologies Market Outlook, By Retrovirus (2019-2028) (US $MN)
Table 73 Asia Pacific Gene Delivery Technologies Market Outlook, By Adenovirus (2019-2028) (US $MN)
Table 74 Asia Pacific Gene Delivery Technologies Market Outlook, By Non-Viral (2019-2028) (US $MN)
Table 75 Asia Pacific Gene Delivery Technologies Market Outlook, By Chemical (2019-2028) (US $MN)
Table 76 Asia Pacific Gene Delivery Technologies Market Outlook, By Physical (2019-2028) (US $MN)
Table 77 South America Gene Delivery Technologies Market Outlook, By Country (2019-2028) (US $MN)
Table 78 South America Gene Delivery Technologies Market Outlook, By Method (2019-2028) (US $MN)
Table 79 South America Gene Delivery Technologies Market Outlook, By Ex-Vivo (2019-2028) (US $MN)
Table 80 South America Gene Delivery Technologies Market Outlook, By In-Vivo (2019-2028) (US $MN)
Table 81 South America Gene Delivery Technologies Market Outlook, By In Vitro (2019-2028) (US $MN)
Table 82 South America Gene Delivery Technologies Market Outlook, By Application (2019-2028) (US $MN)
Table 83 South America Gene Delivery Technologies Market Outlook, By Gene Therapy (2019-2028) (US $MN)
Table 84 South America Gene Delivery Technologies Market Outlook, By Cell Therapy (2019-2028) (US $MN)
Table 85 South America Gene Delivery Technologies Market Outlook, By Vaccines (2019-2028) (US $MN)
Table 86 South America Gene Delivery Technologies Market Outlook, By Research (2019-2028) (US $MN)
Table 87 South America Gene Delivery Technologies Market Outlook, By Mode (2019-2028) (US $MN)
Table 88 South America Gene Delivery Technologies Market Outlook, By Biological (2019-2028) (US $MN)
Table 89 South America Gene Delivery Technologies Market Outlook, By Adenoassociated Virus (AAV) (2019-2028) (US $MN)
Table 90 South America Gene Delivery Technologies Market Outlook, By Lentivirus (2019-2028) (US $MN)
Table 91 South America Gene Delivery Technologies Market Outlook, By Retrovirus (2019-2028) (US $MN)
Table 92 South America Gene Delivery Technologies Market Outlook, By Adenovirus (2019-2028) (US $MN)
Table 93 South America Gene Delivery Technologies Market Outlook, By Non-Viral (2019-2028) (US $MN)
Table 94 South America Gene Delivery Technologies Market Outlook, By Chemical (2019-2028) (US $MN)
Table 95 South America Gene Delivery Technologies Market Outlook, By Physical (2019-2028) (US $MN)
Table 96 Middle East & Africa Gene Delivery Technologies Market Outlook, By Country (2019-2028) (US $MN)
Table 97 Middle East & Africa Gene Delivery Technologies Market Outlook, By Method (2019-2028) (US $MN)
Table 98 Middle East & Africa Gene Delivery Technologies Market Outlook, By Ex-Vivo (2019-2028) (US $MN)
Table 99 Middle East & Africa Gene Delivery Technologies Market Outlook, By In-Vivo (2019-2028) (US $MN)
Table 100 Middle East & Africa Gene Delivery Technologies Market Outlook, By In Vitro (2019-2028) (US $MN)
Table 101 Middle East & Africa Gene Delivery Technologies Market Outlook, By Application (2019-2028) (US $MN)
Table 102 Middle East & Africa Gene Delivery Technologies Market Outlook, By Gene Therapy (2019-2028) (US $MN)
Table 103 Middle East & Africa Gene Delivery Technologies Market Outlook, By Cell Therapy (2019-2028) (US $MN)
Table 104 Middle East & Africa Gene Delivery Technologies Market Outlook, By Vaccines (2019-2028) (US $MN)
Table 105 Middle East & Africa Gene Delivery Technologies Market Outlook, By Research (2019-2028) (US $MN)
Table 106 Middle East & Africa Gene Delivery Technologies Market Outlook, By Mode (2019-2028) (US $MN)
Table 107 Middle East & Africa Gene Delivery Technologies Market Outlook, By Biological (2019-2028) (US $MN)
Table 108 Middle East & Africa Gene Delivery Technologies Market Outlook, By Adenoassociated Virus (AAV) (2019-2028) (US $MN)
Table 109 Middle East & Africa Gene Delivery Technologies Market Outlook, By Lentivirus (2019-2028) (US $MN)
Table 110 Middle East & Africa Gene Delivery Technologies Market Outlook, By Retrovirus (2019-2028) (US $MN)
Table 111 Middle East & Africa Gene Delivery Technologies Market Outlook, By Adenovirus (2019-2028) (US $MN)
Table 112 Middle East & Africa Gene Delivery Technologies Market Outlook, By Non-Viral (2019-2028) (US $MN)
Table 113 Middle East & Africa Gene Delivery Technologies Market Outlook, By Chemical (2019-2028) (US $MN)
Table 114 Middle East & Africa Gene Delivery Technologies Market Outlook, By Physical (2019-2028) (US $MN)
Table 1 Global Gene Delivery Technologies Market Outlook, By Region (2019-2028) (US $MN)
Table 2 Global Gene Delivery Technologies Market Outlook, By Method (2019-2028) (US $MN)
Table 3 Global Gene Delivery Technologies Market Outlook, By Ex-Vivo (2019-2028) (US $MN)
Table 4 Global Gene Delivery Technologies Market Outlook, By In-Vivo (2019-2028) (US $MN)
Table 5 Global Gene Delivery Technologies Market Outlook, By In Vitro (2019-2028) (US $MN)
Table 6 Global Gene Delivery Technologies Market Outlook, By Application (2019-2028) (US $MN)
Table 7 Global Gene Delivery Technologies Market Outlook, By Gene Therapy (2019-2028) (US $MN)
Table 8 Global Gene Delivery Technologies Market Outlook, By Cell Therapy (2019-2028) (US $MN)
Table 9 Global Gene Delivery Technologies Market Outlook, By Vaccines (2019-2028) (US $MN)
Table 10 Global Gene Delivery Technologies Market Outlook, By Research (2019-2028) (US $MN)
Table 11 Global Gene Delivery Technologies Market Outlook, By Mode (2019-2028) (US $MN)
Table 12 Global Gene Delivery Technologies Market Outlook, By Biological (2019-2028) (US $MN)
Table 13 Global Gene Delivery Technologies Market Outlook, By Adenoassociated Virus (AAV) (2019-2028) (US $MN)
Table 14 Global Gene Delivery Technologies Market Outlook, By Lentivirus (2019-2028) (US $MN)
Table 15 Global Gene Delivery Technologies Market Outlook, By Retrovirus (2019-2028) (US $MN)
Table 16 Global Gene Delivery Technologies Market Outlook, By Adenovirus (2019-2028) (US $MN)
Table 17 Global Gene Delivery Technologies Market Outlook, By Non-Viral (2019-2028) (US $MN)
Table 18 Global Gene Delivery Technologies Market Outlook, By Chemical (2019-2028) (US $MN)
Table 19 Global Gene Delivery Technologies Market Outlook, By Physical (2019-2028) (US $MN)
Table 20 North America Gene Delivery Technologies Market Outlook, By Country (2019-2028) (US $MN)
Table 21 North America Gene Delivery Technologies Market Outlook, By Method (2019-2028) (US $MN)
Table 22 North America Gene Delivery Technologies Market Outlook, By Ex-Vivo (2019-2028) (US $MN)
Table 23 North America Gene Delivery Technologies Market Outlook, By In-Vivo (2019-2028) (US $MN)
Table 24 North America Gene Delivery Technologies Market Outlook, By In Vitro (2019-2028) (US $MN)
Table 25 North America Gene Delivery Technologies Market Outlook, By Application (2019-2028) (US $MN)
Table 26 North America Gene Delivery Technologies Market Outlook, By Gene Therapy (2019-2028) (US $MN)
Table 27 North America Gene Delivery Technologies Market Outlook, By Cell Therapy (2019-2028) (US $MN)
Table 28 North America Gene Delivery Technologies Market Outlook, By Vaccines (2019-2028) (US $MN)
Table 29 North America Gene Delivery Technologies Market Outlook, By Research (2019-2028) (US $MN)
Table 30 North America Gene Delivery Technologies Market Outlook, By Mode (2019-2028) (US $MN)
Table 31 North America Gene Delivery Technologies Market Outlook, By Biological (2019-2028) (US $MN)
Table 32 North America Gene Delivery Technologies Market Outlook, By Adenoassociated Virus (AAV) (2019-2028) (US $MN)
Table 33 North America Gene Delivery Technologies Market Outlook, By Lentivirus (2019-2028) (US $MN)
Table 34 North America Gene Delivery Technologies Market Outlook, By Retrovirus (2019-2028) (US $MN)
Table 35 North America Gene Delivery Technologies Market Outlook, By Adenovirus (2019-2028) (US $MN)
Table 36 North America Gene Delivery Technologies Market Outlook, By Non-Viral (2019-2028) (US $MN)
Table 37 North America Gene Delivery Technologies Market Outlook, By Chemical (2019-2028) (US $MN)
Table 38 North America Gene Delivery Technologies Market Outlook, By Physical (2019-2028) (US $MN)
Table 39 Europe Gene Delivery Technologies Market Outlook, By Country (2019-2028) (US $MN)
Table 40 Europe Gene Delivery Technologies Market Outlook, By Method (2019-2028) (US $MN)
Table 41 Europe Gene Delivery Technologies Market Outlook, By Ex-Vivo (2019-2028) (US $MN)
Table 42 Europe Gene Delivery Technologies Market Outlook, By In-Vivo (2019-2028) (US $MN)
Table 43 Europe Gene Delivery Technologies Market Outlook, By In Vitro (2019-2028) (US $MN)
Table 44 Europe Gene Delivery Technologies Market Outlook, By Application (2019-2028) (US $MN)
Table 45 Europe Gene Delivery Technologies Market Outlook, By Gene Therapy (2019-2028) (US $MN)
Table 46 Europe Gene Delivery Technologies Market Outlook, By Cell Therapy (2019-2028) (US $MN)
Table 47 Europe Gene Delivery Technologies Market Outlook, By Vaccines (2019-2028) (US $MN)
Table 48 Europe Gene Delivery Technologies Market Outlook, By Research (2019-2028) (US $MN)
Table 49 Europe Gene Delivery Technologies Market Outlook, By Mode (2019-2028) (US $MN)
Table 50 Europe Gene Delivery Technologies Market Outlook, By Biological (2019-2028) (US $MN)
Table 51 Europe Gene Delivery Technologies Market Outlook, By Adenoassociated Virus (AAV) (2019-2028) (US $MN)
Table 52 Europe Gene Delivery Technologies Market Outlook, By Lentivirus (2019-2028) (US $MN)
Table 53 Europe Gene Delivery Technologies Market Outlook, By Retrovirus (2019-2028) (US $MN)
Table 54 Europe Gene Delivery Technologies Market Outlook, By Adenovirus (2019-2028) (US $MN)
Table 55 Europe Gene Delivery Technologies Market Outlook, By Non-Viral (2019-2028) (US $MN)
Table 56 Europe Gene Delivery Technologies Market Outlook, By Chemical (2019-2028) (US $MN)
Table 57 Europe Gene Delivery Technologies Market Outlook, By Physical (2019-2028) (US $MN)
Table 58 Asia Pacific Gene Delivery Technologies Market Outlook, By Country (2019-2028) (US $MN)
Table 59 Asia Pacific Gene Delivery Technologies Market Outlook, By Method (2019-2028) (US $MN)
Table 60 Asia Pacific Gene Delivery Technologies Market Outlook, By Ex-Vivo (2019-2028) (US $MN)
Table 61 Asia Pacific Gene Delivery Technologies Market Outlook, By In-Vivo (2019-2028) (US $MN)
Table 62 Asia Pacific Gene Delivery Technologies Market Outlook, By In Vitro (2019-2028) (US $MN)
Table 63 Asia Pacific Gene Delivery Technologies Market Outlook, By Application (2019-2028) (US $MN)
Table 64 Asia Pacific Gene Delivery Technologies Market Outlook, By Gene Therapy (2019-2028) (US $MN)
Table 65 Asia Pacific Gene Delivery Technologies Market Outlook, By Cell Therapy (2019-2028) (US $MN)
Table 66 Asia Pacific Gene Delivery Technologies Market Outlook, By Vaccines (2019-2028) (US $MN)
Table 67 Asia Pacific Gene Delivery Technologies Market Outlook, By Research (2019-2028) (US $MN)
Table 68 Asia Pacific Gene Delivery Technologies Market Outlook, By Mode (2019-2028) (US $MN)
Table 69 Asia Pacific Gene Delivery Technologies Market Outlook, By Biological (2019-2028) (US $MN)
Table 70 Asia Pacific Gene Delivery Technologies Market Outlook, By Adenoassociated Virus (AAV) (2019-2028) (US $MN)
Table 71 Asia Pacific Gene Delivery Technologies Market Outlook, By Lentivirus (2019-2028) (US $MN)
Table 72 Asia Pacific Gene Delivery Technologies Market Outlook, By Retrovirus (2019-2028) (US $MN)
Table 73 Asia Pacific Gene Delivery Technologies Market Outlook, By Adenovirus (2019-2028) (US $MN)
Table 74 Asia Pacific Gene Delivery Technologies Market Outlook, By Non-Viral (2019-2028) (US $MN)
Table 75 Asia Pacific Gene Delivery Technologies Market Outlook, By Chemical (2019-2028) (US $MN)
Table 76 Asia Pacific Gene Delivery Technologies Market Outlook, By Physical (2019-2028) (US $MN)
Table 77 South America Gene Delivery Technologies Market Outlook, By Country (2019-2028) (US $MN)
Table 78 South America Gene Delivery Technologies Market Outlook, By Method (2019-2028) (US $MN)
Table 79 South America Gene Delivery Technologies Market Outlook, By Ex-Vivo (2019-2028) (US $MN)
Table 80 South America Gene Delivery Technologies Market Outlook, By In-Vivo (2019-2028) (US $MN)
Table 81 South America Gene Delivery Technologies Market Outlook, By In Vitro (2019-2028) (US $MN)
Table 82 South America Gene Delivery Technologies Market Outlook, By Application (2019-2028) (US $MN)
Table 83 South America Gene Delivery Technologies Market Outlook, By Gene Therapy (2019-2028) (US $MN)
Table 84 South America Gene Delivery Technologies Market Outlook, By Cell Therapy (2019-2028) (US $MN)
Table 85 South America Gene Delivery Technologies Market Outlook, By Vaccines (2019-2028) (US $MN)
Table 86 South America Gene Delivery Technologies Market Outlook, By Research (2019-2028) (US $MN)
Table 87 South America Gene Delivery Technologies Market Outlook, By Mode (2019-2028) (US $MN)
Table 88 South America Gene Delivery Technologies Market Outlook, By Biological (2019-2028) (US $MN)
Table 89 South America Gene Delivery Technologies Market Outlook, By Adenoassociated Virus (AAV) (2019-2028) (US $MN)
Table 90 South America Gene Delivery Technologies Market Outlook, By Lentivirus (2019-2028) (US $MN)
Table 91 South America Gene Delivery Technologies Market Outlook, By Retrovirus (2019-2028) (US $MN)
Table 92 South America Gene Delivery Technologies Market Outlook, By Adenovirus (2019-2028) (US $MN)
Table 93 South America Gene Delivery Technologies Market Outlook, By Non-Viral (2019-2028) (US $MN)
Table 94 South America Gene Delivery Technologies Market Outlook, By Chemical (2019-2028) (US $MN)
Table 95 South America Gene Delivery Technologies Market Outlook, By Physical (2019-2028) (US $MN)
Table 96 Middle East & Africa Gene Delivery Technologies Market Outlook, By Country (2019-2028) (US $MN)
Table 97 Middle East & Africa Gene Delivery Technologies Market Outlook, By Method (2019-2028) (US $MN)
Table 98 Middle East & Africa Gene Delivery Technologies Market Outlook, By Ex-Vivo (2019-2028) (US $MN)
Table 99 Middle East & Africa Gene Delivery Technologies Market Outlook, By In-Vivo (2019-2028) (US $MN)
Table 100 Middle East & Africa Gene Delivery Technologies Market Outlook, By In Vitro (2019-2028) (US $MN)
Table 101 Middle East & Africa Gene Delivery Technologies Market Outlook, By Application (2019-2028) (US $MN)
Table 102 Middle East & Africa Gene Delivery Technologies Market Outlook, By Gene Therapy (2019-2028) (US $MN)
Table 103 Middle East & Africa Gene Delivery Technologies Market Outlook, By Cell Therapy (2019-2028) (US $MN)
Table 104 Middle East & Africa Gene Delivery Technologies Market Outlook, By Vaccines (2019-2028) (US $MN)
Table 105 Middle East & Africa Gene Delivery Technologies Market Outlook, By Research (2019-2028) (US $MN)
Table 106 Middle East & Africa Gene Delivery Technologies Market Outlook, By Mode (2019-2028) (US $MN)
Table 107 Middle East & Africa Gene Delivery Technologies Market Outlook, By Biological (2019-2028) (US $MN)
Table 108 Middle East & Africa Gene Delivery Technologies Market Outlook, By Adenoassociated Virus (AAV) (2019-2028) (US $MN)
Table 109 Middle East & Africa Gene Delivery Technologies Market Outlook, By Lentivirus (2019-2028) (US $MN)
Table 110 Middle East & Africa Gene Delivery Technologies Market Outlook, By Retrovirus (2019-2028) (US $MN)
Table 111 Middle East & Africa Gene Delivery Technologies Market Outlook, By Adenovirus (2019-2028) (US $MN)
Table 112 Middle East & Africa Gene Delivery Technologies Market Outlook, By Non-Viral (2019-2028) (US $MN)
Table 113 Middle East & Africa Gene Delivery Technologies Market Outlook, By Chemical (2019-2028) (US $MN)
Table 114 Middle East & Africa Gene Delivery Technologies Market Outlook, By Physical (2019-2028) (US $MN)
